Newborn Screening Market – United States

Market Statistics

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 7.90% (2024-2032)

The United States newborn screening market size is expanding rapidly, driven by a combination of public health policies, advancements in medical technology, and growing awareness among parents and healthcare providers. According to the latest report by IMARC Group, the market is projected to grow at a CAGR of 7.90% from 2024 to 2032.

United States Newborn Screening Industry Trends and Drivers:

United States Newborn Screening Market

The United States newborn screening market is experiencing rapid expansion, fueled by various factors including public health policies, medical advancements, and increased awareness among parents and healthcare providers.

Key Drivers of Growth in the U.S. Newborn Screening Market

• Mandates for Newborn Screening Across States:
• • Federal and state governments are expanding the list of conditions screened at birth, ensuring early detection and intervention for genetic, metabolic, and congenital disorders.
  • This proactive approach prevents long-term disabilities and improves the quality of life for affected infants.
• Advancements in Screening Technologies:
• • Technologies such as tandem mass spectrometry (MS/MS) and next-generation sequencing (NGS) allow for more accurate, efficient, and faster detection of a broader spectrum of disorders.
  • These advancements enable simultaneous screening for multiple conditions, reducing both time and costs associated with traditional methods.
• Growing Emphasis on Early Diagnosis and Preventive Healthcare:
• • More hospitals and healthcare facilities are adopting comprehensive newborn screening programs, recognizing the importance of early diagnosis and prevention.
  • This trend is helping drive market growth and expand the reach of screening services.

Increasing Public and Healthcare Provider Awareness

• Educational Campaigns and Government Initiatives:
• • Healthcare organizations and government initiatives are raising awareness about the importance of early detection and treatment of congenital and genetic disorders.
  • Informed parents are increasingly seeking comprehensive screening services for their newborns.
• Improvements in Healthcare Spending and Infrastructure:
• • Increased healthcare spending and improvements in neonatal care are facilitating the widespread adoption of newborn screening across the U.S.
  • Enhanced healthcare infrastructure ensures that screening services reach a larger portion of the population.
• Advancements in Point-of-Care Testing:
• • Point-of-care testing innovations allow for faster and more convenient screening, especially in rural and underserved areas.
  • This innovation increases the accessibility and effectiveness of newborn screening services.
• Expansion of Insurance Coverage and Reimbursement Policies:
• • Expanded insurance coverage and reimbursement policies for newborn screening make these services more accessible to a larger population, further driving market growth.

The U.S. newborn screening market continues to thrive, driven by technological advancements, policy support, and increasing awareness of the benefits of early detection, ultimately enhancing healthcare outcomes for newborns across the country.

Download sample copy of the Report: https://www.imarcgroup.com/united-states-newborn-screening-market/requestsample

United States Newborn Screening Industry Segmentation:

The report has segmented the market into the following categories:

Product Insights:

• Instruments
• Reagents

Technology Insights:

• Tandem Mass Spectrometry
• Pulse Oximetry
• Enzyme Based Assay
• DNA Assay
• Electrophoresis
• Others

Test Type Insights:

• Dry Blood Spot Test
• CCHD
• Hearing Screen

Regional Insights:

• Northeast
• Midwest
• South
• West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Request for customization:  https://www.imarcgroup.com/request?type=report&id=21054&flag=F

Key highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145